Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India
Ocular Oncology and Pathology · 2020 · 6 (1) · 66-73
DOI: 10.1159/000500010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 04.06.2019. Verfasst von Pukhraj Rishi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralya, Chennai, India. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
There are limited reports of intra-arterial chemotherapy (IAC) for retinoblastoma (RB) from developing world.
Objectives
In this study, we report our 4-year experience of IAC for RB from India.
Methods
Retrospective, interventional case series. Primary outcome measures included tumor regression, vitreous seeds and subretinal seeds control, and globe salvage. Secondary outcome measures were best-corrected visual acuity and treatment complications.
Results
Fifteen eyes underwent 53 IAC procedures over mean 28.6 ± 13.8 months (range 10–51 months). IAC was employed as primary (n = 6) or secondary (n = 9) chemotherapy. Following IAC, complete regression of main tumor was seen in 7 eyes (47%) and partial regression in 3 (20%) eyes. Enucleation was done in 5(33%) eyes. Globe salvage rates were achieved in 1 eye (100%) in group B, 2 eyes (67%) in group C (n = 3), 6 eyes (67%) in group D (n = 9), and 1 eye (50%) in group E (n = 2). Following IAC, Kaplan-Meier survival curve showed 93% globe survival rate at 1 year, 76% at 2 years, and 66% at 3, and 4 years.
Conclusion
IAC has enhanced globe salvage rates in eyes with RB. Multicenter studies with longer follow-up are necessary to better understand outcomes in the long term.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralya, Chennai, India.
- Apollo Institute of Interventional Radiology, Apollo Hospital, Chennai, India.
Zitieren
APA
Rishi, P., Agarwal, A., Chatterjee, P., Sharma, T., Sharma, M., Saravanan, M., & Ravikumar, R. (2020). Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India. Ocular Oncology and Pathology, 6(1), 66-73. https://doi.org/10.1159/000500010
Vancouver
Rishi P, Agarwal A, Chatterjee P, Sharma T, Sharma M, Saravanan M, et al. Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India. Ocular Oncology and Pathology. 2020;6(1):66-73. doi:10.1159/000500010
BibTeX
@article{Rishi2020,
author = {Rishi, Pukhraj and Agarwal, Ashutosh and Chatterjee, Pritam and Sharma, Tarun and Sharma, Minal and Saravanan, Munusamy and Ravikumar, R},
title = {Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India},
journal = {Ocular Oncology and Pathology},
year = {2020},
volume = {6},
number = {1},
pages = {66--73},
doi = {10.1159/000500010}
}
EUVIMED